Log in to save to my catalogue

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on t...

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ebf23bc085f4e94b511d6d88dfe8b55

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

About this item

Full title

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001322

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Unleashing adaptive immunity via immune checkpoint inhibitors (ICPIs) in many cancer types led to durable antitumor responses and prolonged survivals and also added some new immune-related adverse events (irAEs) to the ‘old-fashioned’ safety profile of chemotherapy. Among bowel and endocrine irAEs, immune-mediated hepatotoxicity/hepatitis is a less...

Alternative Titles

Full title

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2ebf23bc085f4e94b511d6d88dfe8b55

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ebf23bc085f4e94b511d6d88dfe8b55

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2020-001322

How to access this item